Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.
BACKGROUND
There is a paucity of published data regarding the quality of care of inflammatory bowel disease (IBD) in Canada. Clinical quality indicators are quantitative end points used to guide, monitor and improve the quality of patient care. In Canada, where universal health care can vary significantly among provinces, quality indicators can be used to identify potential gaps in the delivery of IBD care and standardize the approach to interprovincial management.


METHODS
The Emerging Practice in IBD Collaborative (EPIC) group generated a shortlist of IBD quality indicators based on a comprehensive literature review. An iterative voting process was used to select quality indicators to take forward. In a face-to-face meeting with the EPIC group, available evidence to support each quality indicator was presented by the EPIC member aligned to it, followed by group discussion to agree on the wording of the statements. The selected quality indicators were then ratified in a final vote by all EPIC members.


RESULTS
Eleven quality indicators for the management of IBD within the single-payer health care system of Canada were developed. These focus on accurate diagnosis, appropriate and timely management, disease monitoring, and prevention or treatment of complications of IBD or its therapy.


CONCLUSIONS
These quality indicators are measurable, reflective of the evidence base and expert opinion, and define a standard of care that is at least a minimum that should be expected for IBD management in Canada. The next steps for the EPIC group involve conducting research to assess current practice across Canada as it pertains to these quality indicators and to measure the impact of each of these indicators on patient outcomes.
Geoffrey C
GC
Nguyen
Shane M
SM
Devlin
Waqqas
W
Afif
Brian
B
Bressler
Steven E
SE
Gruchy
Gilaad G
GG
Kaplan
Liliana
L
Oliveira
Sophie
S
Plamondon
Cynthia H
CH
Seow
Chadwick
C
Williams
Karen
K
Wong
Brian M
BM
Yan
Jennifer
J
Jones
D002170:Canada; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D019984:Quality Indicators, Health Care; D011787:Quality of Health Care / Q000592:standards*